Chinese tech giant Baidu announced on Monday that it has inked an agreement with Sanofi, a leading biopharmaceutical company focused on human health, to integrate Baidu's messenger ribonucleic acid (mRNA) design optimization platform, LinearDesign, into Sanofi's product design pipeline.
Under the agreement, Sanofi will leverage the LinearDesign platform to contribute to...
